Headquartered in Hayward, California, Intarcia Therapeutics is a force to be reckoned with in the biotech world. It has raised over $1 billion in total equity funding and recently acquired Phoundry Pharmaceuticals for an undisclosed amount.
It hasn’t gone public.
{iframe}http://medcitynews.com/2016/12/private-biotech-funding-skyrocketed-why-bother-going-public/?utm_source=hs_email&utm_medium=email&utm_content=39865242&_hsenc=p2ANqtz–XSzieNlcpqBVWngxeQEFuKEXY5iwxgUYyHb3IIIpNzNCZCOsZXhbPrtR4YpAmgTtoRMforePgCr8aqhqZJFYU4fzwKw&_hsmi=39865242{/iframe}